Veterinary Medicines

Carpcoat 40 mg film-coated tablets for dogs

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Carpcoat 40 mg film-coated tablets for dogs
Carpcoat, 40 mg, plėvele dengtos tabletės šunims
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    40.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • (ID12) 250 Film-coated tablet: Box (board) with 25 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID8) 80 Film-coated tablet: Box (board) with 8 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID6) 60 Film-coated tablet: Box (board) with 6 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID2) 20 Film-coated tablet: Box (board) with 2 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID11) 120 Film-coated tablet: Box (board) with 12 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID9) 90 Film-coated tablet: Box (board) with 9 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID10) 100 Film-coated tablet: Box (board) with 10 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID5) 50 Film-coated tablet: Box (board) with 5 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID1) 10 Film-coated tablet: Box (board) with 1 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) with 10 Film-coated tablet, closed with (Aluminium)
  • (ID4) 40 Film-coated tablet: Box (board) with 4 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID3) 30 Film-coated tablet: Box (board) with 3 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)
  • (ID7) 70 Film-coated tablet: Box (board) with 7 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Film-coated tablet, closed with (Aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Lelypharma B.V.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/25/2914/001-012
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0351/003
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 2/12/2025
Download